Early Progress with Second Neuralink Participant

Today, October 10, 2024, Neuralink shared an update on the progress of their second participant in the PRIME Study. The company’s technology is enabling this individual to play video games and use CAD software, demonstrating the potential of brain-computer interfaces (BCIs) to restore lost functions.

This marks a significant milestone for Neuralink, as it follows the success of their first participant who was able to control a computer cursor with their thoughts. The company’s goal is to develop BCIs that can help people with neurological conditions such as paralysis and blindness.

In addition to the PRIME Study update, Neuralink also announced that they have received Breakthrough Device Designation from the FDA for their Blindsight system. This designation allows the company to accelerate the development and commercialization of their technology.

Neuralink’s progress is exciting and offers hope for the future of BCI technology. The company’s work could revolutionize the lives of millions of people around the world.

Stay tuned for more updates on Neuralink’s progress.